GENZ Stock Quote

Best and worst U.S. stocks in July
Here's a list of the best and worst performing stocks within the S&P 500 for July.

Fri, 30 Jul 2010 23:58:00 GMT

(at MarketWatch)

Winners & Losers From The Week That Was

Fri, 30 Jul 2010 21:52:06 GMT

(at The Wall Street Journal)

What Happened to the Sanofi-Genzyme "Bear Hug" Letter?

Fri, 30 Jul 2010 21:41:33 GMT

(at The Wall Street Journal)

WEEKAHEAD-The view from Reuters editors in the Americas

Fri, 30 Jul 2010 21:01:43 GMT

(at Reuters)

Friday Options Recap

Fri, 30 Jul 2010 20:07:12 GMT

(at Seeking Alpha)

DEALTALK-White knight could be elusive for Genzyme

Fri, 30 Jul 2010 19:37:16 GMT

(at Reuters)

Is Genzyme Worthy of a Sanofi Takeover?
Beyond all of Genzyme's baggage there still may be a solid biotech.

Fri, 30 Jul 2010 16:45:00 GMT

(at Minyanville)

Sanofi Has To Do Something

Fri, 30 Jul 2010 16:06:14 GMT

(at Investopedia)

Sanofi CEO targeting everything but blockbusters
After 20 months running drugmaker Sanofi-Aventis SA, Chris Viehbacher wants to end the roller coaster of revenue peaks and valleys as blockbuster drugs climb to billions in sales and suddenly plummet when generic competition hits.

Fri, 30 Jul 2010 15:55:59 GMT

(AP)

Biotech Stocks: Geron rallies on FDA move; Merck slides
Geron Corp. shares rallied early Friday on news that the U.S. Food and Drug Administration is allowing the company to proceed with the world's first clinical study to test an embryonic-stem-cell therapy on humans.

Fri, 30 Jul 2010 14:27:00 GMT

(at MarketWatch)